Biocept Inc.

12/09/2021 | Press release | Distributed by Public on 12/09/2021 07:21

Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain